Form 8-K - Current report:
SEC Accession No. 0001144204-15-033726
Filing Date
2015-05-27
Accepted
2015-05-27 15:44:21
Documents
6
Period of Report
2015-05-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v411785_8-k.htm 8-K 21044
2 EXHIBIT 99.1 v411785_ex99-1.htm EX-99.1 13162
3 EXHIBIT 99.2 v411785_ex99-2.htm EX-99.2 23400
4 EXHIBIT 99.3 v411785_ex99-3.htm EX-99.3 8566
5 EXHIBIT 99.4 v411785_ex99-4.htm EX-99.4 8921
6 GRAPHIC logo.jpg GRAPHIC 4686
  Complete submission text file 0001144204-15-033726.txt   82954
Mailing Address 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address 3301 AGRICULTURE DRIVE MADISON WI 53716 617-244-1616
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 15892306
SIC: 2834 Pharmaceutical Preparations